SIM
GILD icon

Stratos Investment Management’s Gilead Sciences GILD Stock Holding History

Stratos Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$404K Sell
3,199
-1,432
-31% -$189K 0.01% 284
2026
Q1 		$645K Sell
4,631
-139
-3% -$19.5K 0.03% 228
2025
Q4 		$586K Buy
4,770
+48
+1% +$5.83K 0.02% 227
2025
Q3 		$524K Buy
4,722
+246
+5% +$28K 0.02% 240
2025
Q2 		$496K Buy
4,476
+570
+15% +$60.7K 0.02% 253
2025
Q1 		$438K Buy
3,906
+1,011
+35% +$104K 0.02% 219
2024
Q4 		$267K Buy
2,895
+170
+6% +$15.3K 0.02% 226
2024
Q3 		$229K Sell
2,725
-32,537
-92% -$2.48M 0.02% 228
2024
Q2 		$2.42M Buy
35,262
+4,060
+13% +$271K 0.2% 94
2024
Q1 		$2.29M Buy
+31,202
New +$2.4M 0.22% 87

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stratos Investment Management's GILD Position: Q2 2026 in Review

Stratos Investment Management reduced its Gilead Sciences (GILD) stake by 31% in Q2 2026, selling an estimated $189K and leaving 3,199 shares worth $404K. The position accounts for 0.01% of the portfolio, ranked #284.

Stratos Investment Management first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.42M in Q2 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Stratos Investment Management held 3,199 shares of Gilead Sciences worth $404K as of Q2 2026.
  • Stratos Investment Management sold 1,432 Gilead Sciences shares in Q2 2026, an estimated $189K.
  • Gilead Sciences made up 0.01% of Stratos Investment Management's portfolio in Q2 2026, its #284 holding.
  • Stratos Investment Management first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
  • Stratos Investment Management's Gilead Sciences position peaked at $2.42M in Q2 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Stratos Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.